These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1204278)

  • 1. Clinical pharmacology of nabilone, a cannabinol derivative.
    Lemberger L; Rowe H
    Clin Pharmacol Ther; 1975 Dec; 18(6):720-6. PubMed ID: 1204278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single dose study of nabilone, a synthetic cannabinoid.
    Glass RM; Uhlenhuth EH; Hartel FW; Schuster CR; Fischman MW
    Psychopharmacology (Berl); 1980; 71(2):137-42. PubMed ID: 6108592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose study of nabilone in anxious volunteers.
    Glass RM; Uhlenhuth EH; Hartel FW; Schuster CR; Fischman MW
    J Clin Pharmacol; 1981; 21(S1):383S-396S. PubMed ID: 6117576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
    Bedi G; Cooper ZD; Haney M
    Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1975 Sep; 18(3):287-97. PubMed ID: 1164818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabilone: a potent antiemetic cannabinol with minimal euphoria.
    Herman TS; Jones SE; Dean J; Leigh S; Dorr R; Moon TE; Salmon SE
    Biomedicine; 1977 Dec; 27(9-10):331-4. PubMed ID: 606307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiologic disposition of nabilone, a cannabinol derivative, in man.
    Rubin A; Lemberger L; Warrick P; Crabtree RE; Sullivan H; Rowe H; Obermeyer BD
    Clin Pharmacol Ther; 1977 Jul; 22(1):85-91. PubMed ID: 872500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of bronchial effects of nabilone and terbutaline in healthy and asthmatic subjects.
    Gong H; Tashkin DP; Calvarese B
    J Clin Pharmacol; 1983 Apr; 23(4):127-33. PubMed ID: 6306060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nabilone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A; Holmes B
    Drugs; 1985 Aug; 30(2):127-44. PubMed ID: 2863127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthostatic hypotension after delta 9-tetrahydrocannabinol marihuana inhalation.
    Merritt JC; Cook CE; Davis KH
    Ophthalmic Res; 1982; 14(2):124-8. PubMed ID: 6283454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for evaluation of antianxiety drugs with the use of experimentally induced stress: Comparison of nabilone and diazepam.
    Nakano S; Gillespie HK; Hollister LE
    Clin Pharmacol Ther; 1978 Jan; 23(1):54-62. PubMed ID: 22419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of cannabinol during oral surgery.
    Gregg JM; Campbell RL; Levin KJ; Ghia J; Elliott RA
    Anesth Analg; 1976; 55(2):203-13. PubMed ID: 769605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 17. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 18. An EEG investigation on nabilone, a synthetic cannabinoid, in rabbits.
    Sagratella S; Pézzola A; Scotti de Carolis A
    Pharmacol Res Commun; 1986 Jul; 18(7):653-62. PubMed ID: 3020597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marihuana and setting.
    Hollister LE; Overall JE; Gerber ML
    Arch Gen Psychiatry; 1975 Jun; 32(6):798-801. PubMed ID: 1093507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
    Hill KP; Palastro MD; Gruber SA; Fitzmaurice GM; Greenfield SF; Lukas SE; Weiss RD
    Am J Addict; 2017 Dec; 26(8):795-801. PubMed ID: 28921814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.